Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses

Tatjana Stankovic1, Mike Hubank, Debbie Cronin

  • 1Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, United Kingdom. t.stankovic@bham.ac.uk

Blood
|September 6, 2003
PubMed

Insights

The ATM/p53 DNA damage pathway is crucial in lymphoid tumors. ATM controls most transcriptional responses to DNA damage, including p53-independent survival signals, explaining why TP53-mutant B-cell lymphocytic leukemia is more aggressive.

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • Cellular Signaling

Background:

  • The ATM/p53 pathway is vital for DNA damage response and lymphoid tumor progression.
  • Inactivation of ATM or TP53 genes is common in B-cell lymphocytic leukemia (B-CLL), correlating with aggressive disease.
  • The functional overlap and differences between ATM and p53 pathways in tumor progression remain unclear.

Purpose of the Study:

  • To elucidate the distinct roles of ATM and p53 in the DNA damage response within B-CLL.
  • To compare the transcriptional profiles of B-CLLs with different ATM and TP53 genetic statuses.
  • To understand how ATM and p53 deficiencies contribute to B-CLL aggressiveness.

Main Methods:

  • Microarray analysis was employed to compare gene expression profiles.
  • ATM-mutant, TP53-mutant, and ATM/TP53 wild-type B-CLL samples were analyzed.
  • Transcriptional responses to DNA damage (irradiation) were assessed.

Main Results:

  • ATM function is essential for all transcriptional responses to DNA damage.
  • ATM regulates both proapoptotic (via p53) and prosurvival responses independently of p53.
  • TP53-mutant B-CLLs exhibit greater severity due to combined defective apoptosis and enhanced survival signaling post-DNA damage.
  • Transcriptional profiles are similar in ATM-deficient, TP53-deficient, and wild-type B-CLLs prior to DNA damage.

Conclusions:

  • ATM governs a broader spectrum of transcriptional responses to DNA damage than previously recognized.
  • The distinct roles of ATM and p53 explain differential B-CLL aggressiveness based on mutation status.
  • Damage-induced transcriptional fingerprinting offers a method for tumor stratification and identification of therapeutic targets.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...